Method for determining cholesterol concentration in remnant lipoprotein by immunobinding direct process or immuno-precipitation separation process
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 上海北加生化试剂有限公司
- Publication Date
- 2006-12-20
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field:
[0001] The invention relates to a method for measuring the concentration of lipoprotein remnants (RLP) in serum or plasma, in particular to the method for measuring the concentration of lipoprotein remnants (RLP) in serum or plasma by immunobinding direct method or immunoprecipitation separation method, as a clinical judgment Atherosclerotic disease, coronary heart disease, and atherosclerotic-related metabolic disease degree and curative effect evaluation, the reference basis for prognosis judgment. Background technique:
[0002] Remnant lipoprotein (RLP), also known as triglyceride (TG)-rich lipoprotein remnant (TRL), is chylomicron (chylomicron, CM) and very low density lipoprotein (very low density lipoprotein, After being hydrolyzed by lipoprotein lipase (lipoprotein lipase, LPL), triglycerides, phospholipids, apolipoprotein A (apoA, apoA) and apoC are gradually lost, and VLDL is transformed into a smaller protein rich in cholesterol, cholesteryl lipid ...